[Management of toxicities from immunotherapy]
Deutsche Medizinische Wochenschrift (1946)
|August 27, 2021
Summary
Checkpoint inhibitor immunotherapy, using agents targeting CTLA4 or PD-1/PD-L1, requires managing immune-related adverse events (irAEs). This guide outlines prevention, diagnosis, and treatment strategies for irAEs in cancer patients.
Area of Science:
- Oncology
- Immunology
Background:
- Immunotherapy utilizing checkpoint inhibitors (targeting CTLA4, PD-1, or PD-L1) is a standard cancer treatment.
- Immune-related adverse events (irAEs) are common and can affect any organ system.
- irAEs can manifest early, late, or even after treatment cessation, up to two years post-therapy.
Purpose of the Study:
- To provide a comprehensive overview of managing patients undergoing immunotherapy who experience irAEs.
- To detail the prevention, diagnostic approaches, and treatment modalities for irAEs.
Main Methods:
- Grading of irAEs using Common Terminology Criteria for Adverse Events (CTCAE).
- Treatment strategies encompass local/symptomatic care, corticosteroids, and other immunosuppressants based on severity.
Main Results:
- The article presents a general approach to irAE management.
- It covers the spectrum of irAEs, their timing, and grading.
Conclusions:
- Effective management of irAEs is crucial for continuing immunotherapy.
- A systematic approach to prevention, diagnosis, and treatment optimizes patient outcomes.
Related Concept Videos
Tumor Immunotherapy
771
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
771
Prevention of Further Absorption of Poison
976
In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
976
Toxic Reactions: Overview
1.3K
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
1.3K
Myocarditis IV: Nursing Management
61
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
61
Kidney Transplant III: Nursing Management
108
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
108
Therapeutic Drug Monitoring: Affecting Factors
32
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
32


